Amlodipine inhibits bFGF-induced human VSMC proliferation by suppressing p42/p44 MAPKs activation, providing a molecular mechanism for its antiproliferative effects.
No takes yet. Share an insight, caveat, or question.
May extend mechanistic understanding of amlodipine in VSMCs; hypothesis-generating and leaves open clinical translation.
Zhang et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: